Finance

Lists
CTRE:NYSE
Caretrust REIT Inc
$38.22
-1.07%
(-0.41) 1D
Sep 14, 2:07:43 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CTRE...
Open
$39.06
High
$39.39
Low
$38.19
Mkt. cap
9.03B
Avg. vol.
2.16M
Volume
769.67K
Dividend
3.79%
Quarterly dividend
$0.36
Ex-dividend date
Jun 30, 2026
P/E ratio
24.10
52-wk high
$43.62
52-wk low
$32.79
EPS
$1.59
Beta
0.74
Shares outstanding
236.29M
No. of employees
43
Open
$39.06
High
$39.39
Low
$38.19
Mkt. cap
9.03B
Avg. vol.
2.16M
Volume
769.67K
Dividend
3.79%
Quarterly dividend
$0.36
Ex-dividend date
Jun 30, 2026
P/E ratio
24.10
52-wk high
$43.62
52-wk low
$32.79
EPS
$1.59
Beta
0.74
Shares outstanding
236.29M
No. of employees
43
News stories
From web sources and news partners
About Caretrust REIT Inc
CEO-
Employees43
Founded2013
HeadquartersDana Point, California, United States
SectorReal estate investment trust
Websitecaretrustreit.com
Analyst ratings
Based on 8 analysts giving stock ratings to CTRE in the past 3 months
Strong buy
Buy
6
Hold
2
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for CTRE in the last 3 months.
Highest
Current $38.22
$49.00 (+28.21%)
Average
$45.29 (+18.50%)
Lowest
$43.00 (+12.51%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Huntington Capital Markets
Buy
Initiated
-
-
09/10/2026
John Kilichowski
Wells Fargo
Buy
Reiterated
$44.00
+15.1%
09/01/2026
Unknown Analyst
UBS
Buy
Reiterated
$48.00
+25.6%
08/21/2026
Michael Carroll
RBC Capital
Hold
Downgraded
$43.00
+12.5%
08/14/2026
Farrell Granath
Bank of America Securities
Buy
Reiterated
$49.00
+28.2%
08/14/2026
Richard Anderson
Cantor Fitzgerald
Hold
Maintained
$43.00
+12.5%
08/10/2026
Unknown Analyst
Raymond James
Buy
Initiated
$43.00
+12.5%
06/16/2026
Dave Rodgers
Raymond James
Buy
Initiated
$43.00
+12.5%
06/16/2026
Juan C. Sanabria
BMO Capital
Buy
Maintained
$47.00
+23%
06/15/2026
Austin Wurschmidt
KeyBanc
Buy
Maintained
$46.00
+20.4%
05/29/2026
Vikram Malhotra
Mizuho Securities
Buy
Maintained
$45.00
+17.7%
05/25/2026
Unknown Analyst
Deutsche Bank
Buy
Maintained
$43.00
+12.5%
03/23/2026
Michael Goldsmith
UBS
Buy
Maintained
$48.00
+25.6%
02/18/2026
Last report
Aug 7, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.39 / $0.39
+0.28%beat
Revenue / Est. (USD)
161.35M / 156.14M
+3.33%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
132.44M
134.86M
142.78M
161.35M
Cost of goods sold
2.60M
1.75M
5.86M
10.56M
Cost of revenue
2.60M
1.75M
5.86M
10.56M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.42M
15.47M
14.34M
15.78M
Operating expense
42.11M
42.62M
43.77M
46.14M
Total operating expenses
44.72M
44.37M
49.62M
56.70M
Operating income
87.73M
90.49M
93.16M
104.65M
Other non operating income
-
4.35M
-
-
EBT including unusual items
77.01M
114.16M
81.78M
90.77M
EBT excluding unusual items
74.81M
83.36M
81.98M
89.40M
Income tax expense
2.08M
1.89M
2.27M
2.54M
Effective tax rate
2.70%
1.66%
2.78%
2.79%
Other operating expenses
-
-
-
-
Net income
74.90M
111.29M
80.21M
89.00M
Net profit margin
56.55%
82.52%
56.18%
55.16%
Earnings per share
0.33
0.36
0.36
0.39
Interest and investment income
-
-
-
-
Interest expense
-12.62M
-11.38M
-11.24M
-15.32M
Net interest expenses
-12.62M
-11.38M
-11.24M
-15.32M
Depreciation and amortization charges
26.69M
27.14M
29.43M
30.36M
EBITDA
109.64M
117.60M
122.63M
135.01M
Gain or loss from assets sale
-
-27.67M
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps